• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-二聚体在 COVID-19 中的诊断价值:荟萃分析和荟萃回归。

Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression.

机构信息

Department of Clinical Laboratory, 34732Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

State Key Laboratory of Complex, Severe and Rare Diseases, 34732Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

出版信息

Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010976. doi: 10.1177/10760296211010976.

DOI:10.1177/10760296211010976
PMID:33926262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8114749/
Abstract

The prognostic role of hypercoagulability in COVID-19 patients is ambiguous. D-dimer, may be regarded as a global marker of hemostasis activation in COVID-19. Our study was to assess the predictive value of D-dimer for the severity, mortality and incidence of venous thromboembolism (VTE) events in COVID-19 patients. PubMed, EMBASE, Cochrane Library and Web of Science databases were searched. The pooled diagnostic value (95% confidence interval [CI]) of D-dimer was evaluated with a bivariate mixed-effects binary regression modeling framework. Sensitivity analysis and meta regression were used to determine heterogeneity and test robustness. A Spearman rank correlation tested threshold effect caused by different cut offs and units in D-dimer reports. The pooled sensitivity of the prognostic performance of D-dimer for the severity, mortality and VTE in COVID-19 were 77% (95% CI: 73%-80%), 75% (95% CI: 65%-82%) and 90% (95% CI: 90%-90%) respectively, and the specificity were 71% (95% CI: 64%-77%), 83% (95% CI: 77%-87%) and 60% (95% CI: 60%-60%). D-dimer can predict severe and fatal cases of COVID-19 with moderate accuracy. It also shows high sensitivity but relatively low specificity for detecting COVID-19-related VTE events, indicating that it can be used to screen for patients with VTE.

摘要

新冠肺炎患者高凝状态的预后作用尚不清楚。D-二聚体可能被视为新冠肺炎中止血激活的整体标志物。本研究旨在评估 D-二聚体对新冠肺炎患者严重程度、死亡率和静脉血栓栓塞(VTE)事件发生率的预测价值。检索了 PubMed、EMBASE、Cochrane 图书馆和 Web of Science 数据库。采用双变量混合效应二分类回归模型框架评估 D-二聚体的汇总诊断价值(95%置信区间[CI])。使用敏感性分析和荟萃回归来确定异质性并检验稳健性。Spearman 秩相关检验了 D-二聚体报告中不同截断值和单位引起的阈值效应。D-二聚体对新冠肺炎严重程度、死亡率和 VTE 的预后性能的汇总敏感性分别为 77%(95%CI:73%-80%)、75%(95%CI:65%-82%)和 90%(95%CI:90%-90%),特异性分别为 71%(95%CI:64%-77%)、83%(95%CI:77%-87%)和 60%(95%CI:60%-60%)。D-二聚体可以预测新冠肺炎的严重和致命病例,具有中等准确性。它对检测新冠肺炎相关 VTE 事件的灵敏度较高,但特异性相对较低,表明它可用于筛选 VTE 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e4/8114749/870266bd2911/10.1177_10760296211010976-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e4/8114749/a244568d845b/10.1177_10760296211010976-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e4/8114749/c06f3ce3fbc4/10.1177_10760296211010976-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e4/8114749/870266bd2911/10.1177_10760296211010976-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e4/8114749/a244568d845b/10.1177_10760296211010976-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e4/8114749/c06f3ce3fbc4/10.1177_10760296211010976-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e4/8114749/870266bd2911/10.1177_10760296211010976-fig3.jpg

相似文献

1
Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression.D-二聚体在 COVID-19 中的诊断价值:荟萃分析和荟萃回归。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010976. doi: 10.1177/10760296211010976.
2
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.用于预测危重症 COVID-19 患者静脉血栓栓塞症的生物标志物。
Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15.
3
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.COVID-19 患者的入院 D-二聚体水平、D-二聚体趋势和结局。
Thromb Res. 2020 Dec;196:99-105. doi: 10.1016/j.thromres.2020.08.032. Epub 2020 Aug 20.
4
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.COVID-19 患者接受抗栓治疗时的静脉血栓栓塞症的系统评估:发生率和 D-二聚体作为预测因素的作用。
J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z.
5
D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis.D-二聚体水平与 COVID-19 严重程度:系统评价和荟萃分析。
Tuberk Toraks. 2020 Dec;68(4):353-360. doi: 10.5578/tt.70351.
6
Diagnostic accuracy of biomarker D-dimer in patients after stroke suspected from venous thromboembolism: A diagnostic meta-analysis.生物标志物D-二聚体在疑似静脉血栓栓塞性卒中患者中的诊断准确性:一项诊断性荟萃分析。
Clin Biochem. 2019 Jan;63:126-134. doi: 10.1016/j.clinbiochem.2018.09.011. Epub 2018 Sep 24.
7
Utility and limitations of patient-adjusted D-dimer cut-off levels for diagnosis of venous thromboembolism-A systematic review and meta-analysis.患者调整 D-二聚体截断值在静脉血栓栓塞症诊断中的作用和局限性:系统评价和荟萃分析。
J Intern Med. 2023 Jul;294(1):110-120. doi: 10.1111/joim.13650. Epub 2023 May 14.
8
Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.D-二聚体与 SARS-CoV-2 患者严重程度和死亡率的关系:一项荟萃分析。
Int J Lab Hematol. 2021 Feb;43(1):110-115. doi: 10.1111/ijlh.13336. Epub 2020 Sep 15.
9
Plasma D-dimer value corrected by inflammatory markers in patients with SARS-CoV-2 infection: Its prognostic value in the diagnosis of venous thromboembolism.新型冠状病毒感染患者经炎症标志物校正的血浆 D-二聚体值:其在静脉血栓栓塞症诊断中的预后价值。
Med Clin (Barc). 2022 Mar 25;158(6):265-269. doi: 10.1016/j.medcli.2021.03.034. Epub 2021 Jun 3.
10
Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: A systematic review with meta-analysis.: VTE recurrence and D-dimer.D-二聚体检测对复发性静脉血栓栓塞症的诊断准确性:系统评价与荟萃分析:VTE 复发和 D-二聚体。
Eur J Intern Med. 2021 Jul;89:39-47. doi: 10.1016/j.ejim.2021.04.004. Epub 2021 Apr 29.

引用本文的文献

1
Multimarker Approach: An Effective Tool in the Risk Stratification of Patients Admitted to the Emergency Department.多标志物方法:急诊科收治患者风险分层的有效工具。
J Clin Lab Anal. 2025 Sep;39(17):e70084. doi: 10.1002/jcla.70084. Epub 2025 Aug 5.
2
Differences in Clinical and Laboratory Features of Pregnant and Non-Pregnant Female with Hospitalized COVID-19.住院 COVID-19 孕妇与非孕妇临床及实验室特征的差异。
Iran J Nurs Midwifery Res. 2025 May 8;30(3):322-331. doi: 10.4103/ijnmr.ijnmr_86_23. eCollection 2025 May-Jun.
3
Inflammatory biomarkers and adverse outcome in COVID-19: Prelude for future viral pandemics.

本文引用的文献

1
The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients.新冠肺炎患者高 D-二聚体水平的预后不良及其影响因素。
Sci Rep. 2021 Jan 19;11(1):1830. doi: 10.1038/s41598-021-81300-w.
2
Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis.新型冠状病毒肺炎患者的深静脉血栓形成:一项队列分析。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620982669. doi: 10.1177/1076029620982669.
3
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.COVID-19 中的抗凝治疗:依诺肝素、肝素和阿哌沙班对死亡率的影响。
新冠病毒肺炎中的炎症生物标志物与不良结局:未来病毒性大流行的前奏
J Family Med Prim Care. 2025 Feb;14(2):720-728. doi: 10.4103/jfmpc.jfmpc_1326_24. Epub 2025 Feb 21.
4
Predictive modelling and identification of critical variables of mortality risk in COVID-19 patients.2019冠状病毒病患者死亡风险的预测建模及关键变量识别
Sci Rep. 2025 Jan 16;15(1):2184. doi: 10.1038/s41598-023-46712-w.
5
CT pulmonary angiography in the inpatients: A 5-year retrospective view at the end of COVID-19 public health emergency.住院患者的 CT 肺动脉造影:COVID-19 公共卫生紧急事件结束后的 5 年回顾性观察。
Medicine (Baltimore). 2024 Nov 8;103(45):e40351. doi: 10.1097/MD.0000000000040351.
6
Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19.凝血纤溶标志物与 COVID-19 患者严重程度的关系。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241298233. doi: 10.1177/10760296241298233.
7
Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in China.中国新冠疫情爆发前、期间及之后的急性闭角型青光眼。
Heliyon. 2024 Sep 25;10(19):e38404. doi: 10.1016/j.heliyon.2024.e38404. eCollection 2024 Oct 15.
8
Evaluation of d-dimer as outcome biomarker in COVID-19 acute respiratory distress patients.评估 D-二聚体作为 COVID-19 急性呼吸窘迫患者的结局生物标志物。
Rev Inst Med Trop Sao Paulo. 2024 Sep 23;66:e57. doi: 10.1590/S1678-9946202466057. eCollection 2024.
9
Dynamic changes of hematological and hemostatic parameters in COVID-19 hospitalized patients: Potential role as severity biomarkers for the Chilean population.新冠病毒肺炎住院患者血液学和止血参数的动态变化:对智利人群作为疾病严重程度生物标志物的潜在作用
J Med Biochem. 2024 Jun 15;43(4):556-564. doi: 10.5937/jomb0-47588.
10
Increased levels of circulating cell-free DNA in COVID-19 patients with respiratory failure.新冠肺炎呼吸衰竭患者循环游离 DNA 水平升高。
Sci Rep. 2024 Jul 29;14(1):17399. doi: 10.1038/s41598-024-68433-4.
Thromb Haemost. 2020 Dec;120(12):1691-1699. doi: 10.1055/s-0040-1720978. Epub 2020 Nov 13.
4
Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.2019年冠状病毒病住院患者D-二聚体水平的变化趋势及诊断价值
Medicine (Baltimore). 2020 Nov 13;99(46):e23186. doi: 10.1097/MD.0000000000023186.
5
Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.危重症 COVID-19 患者接受高于标准低分子肝素剂量和阿司匹林治疗时的静脉血栓栓塞和出血:行动呼吁。
Thromb Res. 2020 Dec;196:313-317. doi: 10.1016/j.thromres.2020.09.013. Epub 2020 Sep 13.
6
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.D-二聚体升高和未抗凝与重症 COVID-19 患者的 PE 相关。
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.01811-2020. Print 2020 Oct.
7
COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes.健康患者人群中的 COVID-19:人口统计学和临床表型特征以及住院结局的预测因素。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2764-2775. doi: 10.1161/ATVBAHA.120.314845. Epub 2020 Sep 10.
8
Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.新型冠状病毒病(COVID-19)不同严重程度的炎症和非炎症指标的差异。
Infect Genet Evol. 2020 Nov;85:104511. doi: 10.1016/j.meegid.2020.104511. Epub 2020 Aug 26.
9
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients.COVID-19 住院患者深静脉血栓形成的发生率及危险因素。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620953217. doi: 10.1177/1076029620953217.
10
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.COVID-19 患者的入院 D-二聚体水平、D-二聚体趋势和结局。
Thromb Res. 2020 Dec;196:99-105. doi: 10.1016/j.thromres.2020.08.032. Epub 2020 Aug 20.